Study guide

5.1 Cerebrovascular Disease, Stroke & Transients

USMLE Step 2 CK Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Human Development & Well-Patient Care

1.1 Infant, Child & Adolescent Development & Growth 1.2 Adult Development, Aging & Geriatric Assessment 1.3 Preventive Health, Immunization & Well-Patient Screening

2 Chapter 2: Immune System & Immunologic Disorders

2.1 Primary & Secondary Immunodeficiencies 2.2 Hypersensitivity Reactions, Allergy & Anaphylaxis 2.3 Autoimmune & Rheumatologic Disease Principles

3 Chapter 3: Blood & Lymphoreticular System

3.1 Anemias: Microcytic, Normocytic & Macrocytic Etiologies 3.2 Bleeding Disorders, Coagulopathies & Platelet Pathology 3.3 Hematologic Malignancies & Lymphoproliferative Disorders

4 Chapter 4: Behavioral Health & Psychiatric Disorders

4.1 Mood Disorders: Major Depression & Bipolar Spectrum 4.2 Anxiety, Trauma-Related & Somatic Symptom Disorders 4.3 Psychotic Disorders & Schizophrenia Spectrum 4.4 Substance Use Disorders & Psychopharmacology

5 Chapter 5: Nervous System & Special Senses

5.1 Cerebrovascular Disease, Stroke & Transients 5.2 Seizures, Epilepsy & Altered Mental Status 5.3 Movement Disorders, Dementia & Peripheral Neuropathies 5.4 Special Senses: Ophthalmologic & Otolaryngologic Emergencies

6 Chapter 6: Musculoskeletal System & Dermatology

6.1 Fractures, Dislocations & Orthopedic Trauma 6.2 Inflammatory Arthropathies & Crystal-Induced Diseases 6.3 Inflammatory & Infectious Dermatoses 6.4 Cutaneous Malignancies & Blistering Disorders

7 Chapter 7: Cardiovascular System

7.1 Coronary Artery Disease & Acute Coronary Syndromes 7.2 Heart Failure, Cardiomyopathies & Valvular Disease 7.3 Cardiac Arrhythmias, Conduction Blocks & EKG Interpretation 7.4 Vascular Emergencies: Aortic Aneurysms & Peripheral Arterial Disease

8 Chapter 8: Respiratory System

8.1 Obstructive Airway Diseases: Asthma & COPD 8.2 Infectious Pneumonias & Pleural Effusions 8.3 Pulmonary Vascular Disease & Thromboembolism 8.4 Acute Respiratory Distress Syndrome & Interstitial Lung Diseases

9 Chapter 9: Gastrointestinal System

9.1 Esophageal, Gastric & Peptic Ulcer Disorders 9.2 Inflammatory Bowel Disease & Colorectal Neoplasms 9.3 Hepatic Disorders, Cirrhosis & Portal Hypertension 9.4 Biliary Tract Diseases & Pancreatitis

10 Chapter 10: Renal, Urinary & Reproductive Systems

10.1 Acute Kidney Injury & Chronic Kidney Disease 10.2 Glomerular & Tubulointerstitial Diseases 10.3 Nephrolithiasis, Urinary Tract Infections & Prostate Pathology 10.4 Fluid, Electrolyte & Acid-Base Disorders 10.5 Female Reproductive Disorders & Gynecology 10.6 Breast Pathology & Clinical Breast Disease

11 Chapter 11: Pregnancy, Childbirth & Puerperium

11.1 Normal Prenatal Care & Maternal-Fetal Physiology 11.2 Medical & Obstetric Complications of Pregnancy 11.3 Labor, Delivery & Postpartum Management

12 Chapter 12: Endocrine System

12.1 Diabetes Mellitus, Hypoglycemia & Metabolic Emergencies 12.2 Thyroid & Parathyroid Disorders 12.3 Adrenal & Pituitary Axis Pathology

13 Chapter 13: Multisystem Processes & Critical Care

13.1 Shock States, Sepsis & Systemic Inflammatory Response 13.2 Environmental Emergencies, Toxicology & Overdose 13.3 Infectious Disease Principles & Systemic Pathogens

14 Chapter 14: Biostatistics, Epidemiology & Literature Interpretation

14.1 Study Designs, Bias & Validity 14.2 Diagnostic Testing: Sensitivity, Specificity, PPV & NPV 14.3 Statistical Significance, Risk Measures & Evidence-Based Medicine

15 Chapter 15: Social Sciences, Ethics & Systems-Based Practice

15.1 Medical Ethics, Informed Consent & Patient Autonomy 15.2 Legal Issues, Confidentiality & Surrogate Decision Making 15.3 Patient Safety, Quality Improvement & Medical Error Analysis 15.4 Health Care Delivery Systems, Interprofessional Care & Transitions

5.1 Cerebrovascular Disease, Stroke & Transients

Key Takeaways Explain This Topic AI

Intravenous alteplase (rtPA) must be administered within 4.5 hours of symptom onset in eligible ischemic stroke patients with blood pressure controlled <185/110 mmHg, maintaining BP <180/105 mmHg for 24 hours post-infusion.

Mechanical thrombectomy is indicated for large vessel occlusion (LVO) of the anterior circulation up to 24 hours from last known normal, guided by neuroimaging mismatch.

Transient ischemic attack (TIA) risk stratification uses the ABCD2 score; scores of 4 or higher indicate high early stroke risk requiring dual antiplatelet therapy (DAPT: aspirin + clopidogrel) for 21 days.

Subarachnoid hemorrhage presents with sudden thunderclap headache, diagnosed by non-contrast head CT (>95% sensitivity within 6 hours); if CT is negative, lumbar puncture showing xanthochromia is mandatory.

Vasospasm post-subarachnoid hemorrhage peaks between days 3 and 14 and is prevented using oral nimodipine (60 mg every 4 hours for 21 days).

Last updated: July 2026

Hyperacute Evaluation & Initial Diagnostic Protocol

Acute cerebrovascular events represent a leading cause of long-term disability and mortality. Rapid, methodical assessment is required to restore cerebral perfusion while preventing catastrophic bleeding complications. The initial clinical priority in any patient presenting with acute focal neurological deficits is establishing the exact time of last known normal (LKN) and immediately obtaining a non-contrast computed tomography (NCCT) scan of the head.

Vascular Territory Stroke Syndromes

Localization of focal ischemia based on clinical presentation relies on understanding cerebrovascular anatomy:

Vascular Territory Primary Clinical Manifestations High-Yield Clinical Pearls

Anterior Cerebral Artery (ACA) Contralateral motor and sensory deficits affecting the lower extremity > upper extremity ; urinary incontinence; abulia and gait apraxia Sparing of face and arm; motor loss localized to leg and foot

Middle Cerebral Artery (MCA) Contralateral motor and sensory deficits affecting face and upper extremity > lower extremity ; homonymous hemianopia Dominant hemisphere (left): Aphasia (Broca's non-fluent vs. Wernicke's fluent); Non-dominant hemisphere (right): Hemineglect and anosognosia

Posterior Cerebral Artery (PCA) Contralateral homonymous hemianopia with macular sparing ; visual agnosia Dominant lesion: Alexia without agraphia (splenium of corpus callosum involvement)

Vertebrobasilar System "Crossed" deficits (ipsilateral cranial nerve palsies with contralateral motor/sensory loss); the 5 Ds : Dizziness, Diplopia, Dysarthria, Dysphagia, Dystaxia Wallenberg (Lateral Medullary) Syndrome: PICA occlusion → ipsilateral Horner syndrome, facial loss of pain/temp, ataxia, dysphagia, contralateral body pain/temp loss

Reperfusion Therapies: Thrombolysis & Mechanical Thrombectomy

Therapeutic management of acute ischemic stroke depends heavily on time elapsed since LKN, blood pressure parameters, and vascular imaging. [ Acute Focal Deficit / Suspected Stroke ]

  • |
  • (NCCT Head + Blood Glucose)
  • |
  • +------------------------+------------------------+
  • | |
  • [ Intracranial Hemorrhage ] [ No Hemorrhage (Ischemic) ]
  • | |
  • (BP Control + Reversal of (Check Time & BP)
  • Anticoagulation + Neurosurg) |
  • +------------------------+------------------------+
  • | |
  • [ LKN ≤ 4.5 Hours ] [ LKN > 4.5 Hours ]
  • | |
  • (Check rtPA Contraindications) (CTA / MRA for LVO)
  • | |
  • +-----------+-----------+ +-----------+-----------+
  • | | | |
  • [ Eligible ] [ Ineligible ] [ LVO Present ] [ No LVO ]
  • | | | |
  • (Lower BP <185/110; (Aspirin 162-325 mg; (EVT up to 24h if (Aspirin + Statin;
  • Administer rtPA) CTA for EVT) perfusion mismatch) Subacute Workup)
  • Intravenous Alteplase (rtPA) Criteria

Intravenous tissue plasminogen activator (rtPA) should be administered to eligible patients within 4.5 hours of LKN. Blood pressure must be lowered below 185/110 mmHg prior to initiation (e.g., using IV labetalol or nicardipine) and maintained below 180/105 mmHg for 24 hours post-infusion.

Absolute Contraindications to rtPA:

Active internal bleeding or bleeding diathesis (platelets <100,000/mm³, INR >1.7, or use of direct oral anticoagulants within 48 hours)

  • Evidence of intracranial hemorrhage on initial NCCT
  • Head trauma or ischemic stroke within the preceding 3 months
  • History of prior intracranial hemorrhage, arteriovenous malformation, or aneurysm
  • Intracranial or intraspinal surgery within 3 months
  • Severe uncontrolled hypertension (BP >185/110 mmHg unresponsive to acute antihypertensive therapy)
  • Blood glucose <50 mg/dL (must correct hypoglycemia first as it mimics stroke)
  • Endovascular Thrombectomy (EVT)

Mechanical thrombectomy with a stent retriever is indicated for patients with a demonstrated large vessel occlusion (LVO) in the anterior circulation (internal carotid artery or M1 segment MCA). EVT can be performed up to 24 hours from LKN if CT perfusion or MRI demonstrates a favorable mismatch between a small core infarct and a large salvageable penumbra.

Transient Ischemic Attack (TIA) & Risk Stratification

A TIA is defined as a transient episode of neurological dysfunction caused by focal brain, spinal cord, or retinal ischemia without acute tissue infarction on magnetic resonance imaging (MRI) diffusion-weighted imaging (DWI).

ABCD2 Score Risk Stratification

Short-term stroke risk following a TIA is quantified using the ABCD2 score :

  • A ge ≥ 60 years: 1 point
  • B lood Pressure ≥ 140/90 mmHg: 1 point
  • C linical Features: Unilateral weakness ( 2 points ); Speech impairment without weakness ( 1 point )
  • D uration of Symptoms: ≥ 60 minutes ( 2 points ); 10–59 minutes ( 1 point )
  • D iabetes Mellitus: 1 point

Therapeutic Management Based on Score:

High Risk (ABCD2 Score ≥ 4) or Minor Ischemic Stroke (NIHSS ≤ 3): Initiate Dual Antiplatelet Therapy (DAPT) with aspirin (81 mg daily) plus clopidogrel (75 mg daily) within 24 hours of presentation and continue for 21 days , followed by single antiplatelet monotherapy.

Low Risk (ABCD2 Score < 4): Single antiplatelet therapy (aspirin monotherapy 81 mg daily) is recommended.

Carotid Endarterectomy (CEA): Indicated for symptomatic carotid artery stenosis of 70% to 99% if perioperative morbidity risk is <6%. CEA is performed within 2 weeks of symptom onset.

  • Intracranial Hemorrhage & Subarachnoid Hemorrhage
  • Subarachnoid Hemorrhage (SAH)

SAH results predominantly from the rupture of a saccular (berry) aneurysm, most commonly located at the junction of the Anterior Communicating Artery with the anterior cerebral artery.

Presentation: Sudden onset of an excruciating "thunderclap" headache ("worst headache of my life"), often accompanied by transient loss of consciousness, neck stiffness, and subhyaloid retinal hemorrhages.

Diagnostic Algorithm: Perform urgent non-contrast head CT (>95% sensitive within 6 hours). If CT is negative but clinical suspicion remains high, perform a lumbar puncture (LP) . LP finding of xanthochromia (pink/yellow supernatant after centrifugation due to hemoglobin breakdown) confirms SAH.

Complications & Prevention:

Rebleeding: Highest risk within 24 hours; control blood pressure with target SBP <160 mmHg; perform early surgical clipping or endovascular coiling.

Vasospasm / Delayed Cerebral Ischemia: Occurs 3 to 14 days post-bleed. Administer oral nimodipine 60 mg every 4 hours for 21 days to prevent vasospasm.

Hydrocephalus: Communicating hydrocephalus due to arachnoid villi plugging; managed via external ventricular drain (EVD).